Antimicrobial Resistance in Developing Countries (häftad)
Fler böcker inom
Format
Häftad (Paperback / softback)
Språk
Engelska
Antal sidor
554
Utgivningsdatum
2014-09-03
Upplaga
2010 ed.
Förlag
Springer-Verlag New York Inc.
Medarbetare
Amabile, Carlos (ed.), Byarugaba, Denis K. (ed.), Hsueh, Po-Ren (ed.), Kariuki, Samuel (ed.), Okeke, Iruka N. (ed.), Sosa, Aníbal de J. (ed.)
Illustrationer
39 Tables, black and white; XXIII, 554 p.
Dimensioner
234 x 156 x 30 mm
Vikt
804 g
Antal komponenter
1
Komponenter
1 Paperback / softback
ISBN
9781489984258

Antimicrobial Resistance in Developing Countries

av Anbal De J Sosa, Denis K Byarugaba, Carlos F Ambile-Cuevas, Po-Ren Hsueh, Samuel Kariuki
Häftad,  Engelska, 2014-09-03
2233
Köp
Spara som favorit
  • Skickas från oss inom 7-10 vardagar.
  • Fri frakt över 249 kr för privatkunder i Sverige.
Finns även som
Visa alla 2 format & utgåvor
Avoiding infection has always been expensive. Some human populations escaped tropical infections by migrating into cold climates but then had to procure fuel, warm clothing, durable housing, and crops from a short growing season. Waterborne infections were averted by owning your own well or supporting a community reservoir. Everyone got vaccines in rich countries, while people in others got them later if at all. Antimicrobial agents seemed at first to be an exception. They did not need to be delivered through a cold chain and to everyone, as vaccines did. They had to be given only to infected patients and often then as relatively cheap injectables or pills off a shelf for only a few days to get astonishing cures. Antimicrobials not only were better than most other innovations but also reached more of the worlds people sooner. The problem appeared later. After each new antimicrobial became widely used, genes expressing resistance to it began to emerge and spread through bacterial populations. Patients infected with bacteria expressing such resistance genes then failed treatment and remained infected or died. Growing resistance to antimicrobial agents began to take away more and more of the cures that the agents had brought.
Visa hela texten

Passar bra ihop

  1. Antimicrobial Resistance in Developing Countries
  2. +
  3. Bad Therapy

De som köpt den här boken har ofta också köpt Bad Therapy av Abigail Shrier (inbunden).

Köp båda 2 för 2498 kr

Kundrecensioner

Har du läst boken? Sätt ditt betyg »

Fler böcker av författarna

Recensioner i media

Aus den Rezensionen: ... In dem Buch werden von insgesamt 30 Autorinnen (Mikrobiologen und Infektiologen) in hervorragenden bersichtsartikeln all die genannten Probleme dargestellt. Die Literaturangaben sind auf dem neuesten Stand. Fr alle die sich mit Infektionserkrnkungen hier und in armen Lndern beschftigen ist das Buch ein Muss und kann uneingeschrnkt empfohlen werden. (Dr Gerhard Schwarzkopf-Steinhuser, in: Pharma-Brief, May/June/2010, Issue 4-5, S. 4 f.)

Innehållsförteckning

Section I: General Issues in Antimicrobial Resistance. Global perspectives of the Resistance Problem.- Mechanisms of Resistance.- Poverty and Root Causes of Resistance in Developing Countries.- What the Future Holds for Resistance in Developing Countries.- The Introduction of Antimicrobial Agents in Poor-resource Countries: Impact on the Emergence of Resistance.- Section II: The Human Impact of Resistance. HIV Resistance in Developing Countries.- Drug Resistance in Malaria in Developing Countries.- Drug Resistance in Tuberculosis in Developing Countries.- Antifungal Drug Resistance in Developing Countries.- Antimicrobial Resistance in African Trypanosomiasis.- Resistance in Enteric Pathogens in Developing Countries.-Bacterial Resistant Infections in Resource-Limited Countries.- Prevalence of Resistant Enterococci in Developing Countries.- Antimicrobial Resistance in Gram-negative Bacteria from Developing Countries.- Resistance in Reservoirs and Human Commensals.- Section III: Antimicrobial Use and Misuse. Determinants of Antimicrobial Use: Poorly Understood - Poorly Researched.- Antimicrobial Use and Antimicrobial Resistance in African Countries.- Antimicrobial Use and Antimicrobial Resistance in Asian Countries.- Antimicrobial Use and Antimicrobial Resistance in Latin America and the Caribbean Countries.- Hospital Infections by Antimicrobial Resistant Organisms in Developing Countries.- Section IV: Cost, Policy and Regulation of Antimicrobials. Economic Burden of Antimicrobial Resistance.- Health Systems Strengthening to Improve Access to Antimicrobials and the Containment of Resistance.- The Role of Unregulated Sale and Dispensing of Antimicrobial Agents on the Development of Antimicrobial Resistance in Developing Countries.- Counterfeit and Substandard Anti-Infectives in Developing Countries.- Section V: Strategies to contain AMR. Containment of Antimicrobial Resistance in Developing Countries & Lessons Learned.- Surveillance of Antimicrobial Resistance.- Vaccines: A Cost-effective Strategy to Contain Antimicrobial Resistance.- Teaching Antibiotic Prescription Practices in Medical Schools in Developing Countries.- Containing Global Antibiotic Resistance: Ethical Drug Promotion in the Developing World.- News Media Reporting of Antimicrobial Resistance in Latin America and India.

Du kanske gillar